Orchestra BioMed Holdings Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
David Hochman
Chief executive officer
US$6.9m
Total compensation
| CEO salary percentage | 8.6% |
| CEO tenure | 6yrs |
| CEO ownership | 0.6% |
| Management average tenure | 1.7yrs |
| Board average tenure | 5.5yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$52m |
| Dec 31 2023 | US$7m | US$595k | -US$49m |
| Sep 30 2023 | n/a | n/a | -US$48m |
| Jun 30 2023 | n/a | n/a | -US$45m |
| Mar 31 2023 | n/a | n/a | -US$39m |
| Dec 31 2022 | US$3m | US$395k | -US$34m |
| Sep 30 2022 | n/a | n/a | -US$32m |
| Jun 30 2022 | n/a | n/a | -US$27m |
| Mar 31 2022 | n/a | n/a | -US$25m |
| Dec 31 2021 | US$710k | US$395k | -US$23m |
Compensation vs Market: David's total compensation ($USD6.90M) is above average for companies of similar size in the US market ($USD1.55M).
Compensation vs Earnings: David's compensation has increased whilst the company is unprofitable.
CEO
David Hochman (48 yo)
6yrs
Tenure
US$6,899,668
Compensation
Mr. David P. Hochman is Founder & Director at Orchestra BioMed Holdings Inc. (formerly known as Health Sciences Acquisitions Corporation 2) since May 2018 and serves as its Chief Executive Offer and Chairm...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 6yrs | US$6.90m | 0.65% $ 1.2m | |
| Founder | 6yrs | US$6.45m | 0.23% $ 429.8k | |
| Chief Financial Officer | less than a year | US$2.57m | no data | |
| Executive VP of Corporate Development & Strategy | less than a year | no data | no data | |
| GM & CTO of Bioelectronic Therapies | 6yrs | no data | 0.14% $ 254.3k | |
| GM & Senior VP of Focal Therapies | 2.8yrs | no data | 0.056% $ 102.6k | |
| Chief Clinical Officer | 2.1yrs | no data | no data | |
| Senior Vice President of Medical Affairs & Innovation | 1.3yrs | no data | no data | |
| Senior Vice President of Regulatory & Quality | less than a year | no data | no data | |
| Senior Vice President of Product Development | less than a year | no data | no data | |
| Corporate Controller | no data | no data | no data |
1.7yrs
Average Tenure
52yo
Average Age
Experienced Management: OBIO's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 6yrs | US$6.90m | 0.65% $ 1.2m | |
| Founder | 6yrs | US$6.45m | 0.23% $ 429.8k | |
| Independent Director | 5.4yrs | US$138.07k | 0.0061% $ 11.1k | |
| Member of Medical Advisors Board | no data | no data | no data | |
| Member of Medical Advisors Board | no data | no data | no data | |
| Independent Lead Director | 5.5yrs | US$243.42k | 0.083% $ 152.7k | |
| Member of Medical Advisors Board | no data | no data | no data | |
| Independent Director | 5.5yrs | US$145.21k | 0.18% $ 323.1k | |
| Member of Medical Advisors Board | no data | no data | no data | |
| Member of Medical Advisors Board | no data | no data | no data | |
| Member of Medical Advisors Board | no data | no data | no data | |
| Independent Director | 4.3yrs | US$205.42k | 0.012% $ 21.8k |
5.5yrs
Average Tenure
58yo
Average Age
Experienced Board: OBIO's board of directors are considered experienced (5.5 years average tenure).